Pharmacogenomic effects on therapy for acute lymphoblastic leukemia in children

Pharmacogenomics J. 2003;3(3):128-35. doi: 10.1038/sj.tpj.6500174.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Child
  • Humans
  • Pharmacogenetics / methods*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*

Substances

  • Antineoplastic Agents